Get the Stockscreener App
9.43
2.08%
-0.20
Neonc Technologies Holdings Inc stock is traded at $9.43, with a volume of 31,253.
It is down -2.08% in the last 24 hours and up +2.06% over the past month.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
See More
Previous Close:
$9.63
Open:
$9.9
24h Volume:
31,253
Relative Volume:
0.53
Market Cap:
$213.99M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.54%
1M Performance:
+2.06%
6M Performance:
+17.00%
1Y Performance:
+0.00%
1-Day Range:
$9.31
$9.90
1-Week Range:
$8.99
$10.42
52-Week Range:
$3.20
$21.00
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Name
Neonc Technologies Holdings Inc
Sector
Industry
Phone
310 663 7831
Address
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
9.43 | 218.53M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Neonc Technologies Holdings Inc Stock (NTHI) Latest News
NeOnc Technologies Settles Fox Infused Dispute With Payment - TipRanks
NeOnc Technologies settles dispute with Fox Infused for $737,920.77 payment - Investing.com India
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - Bitget
NeOnc sets Phase 2 dose for brain cancer drug NEO212 By Investing.com - Investing.com Australia
Earnings Risk: Will NeOnc Technologies Holdings Inc benefit from government policy2025 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
NeOnc sets Phase 2 dose for brain cancer drug NEO212 - Investing.com Nigeria
New oral brain cancer drug NEO212 shows anti-tumor activity in Phase 1 - Stock Titan
NeOnc Technologies Completes Late-February Private Equity Offerings - TipRanks
NeOnc to Present Initial NEO212 Phase 1 Data - TipRanks
NeOnc to present Phase 1 dose-escalation safety, PK data from NEO212-01 on March 4 - TradingView
NTHIForm 8-KCurrent report - ADVFN Ltd
NeOnc Technologies to present Phase 1 trial data on March 4 - Investing.com Nigeria
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity - Bitget
Early safety data for new CNS cancer pill to be detailed March 4 - Stock Titan
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
Published on: 2026-02-26 08:22:34 - baoquankhu1.vn
NTHI Technical Analysis & ETF Price Forecast - Intellectia AI
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America - Sacramento Bee
User - The Chronicle-Journal
What are analysts’ price targets for NeOnc Technologies Holdings Inc.Bear Alert & Verified Momentum Stock Alerts - mfd.ru
Why NeOnc Technologies Holdings Inc. stock remains resilientPortfolio Growth Summary & Technical Analysis for Trade Confirmation - mfd.ru
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST) - The Desert Sun
Will NeOnc Technologies Holdings Inc. stock outperform value stocksEarnings Growth Report & Weekly Setup with ROI Potential - mfd.ru
Why NeOnc Technologies Holdings Inc. stock is trending among retail traders2025 Buyback Activity & Safe Entry Trade Signal Reports - mfd.ru
Is NeOnc Technologies Holdings Inc. a top pick in the sector2025 Year in Review & Free Weekly Watchlist of Top Performers - mfd.ru
NeOnc Technologies: A New Hope For Aggressive Brain Tumors? - RTTNews
New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America - newswire.com
IPO Launch: How do insiders feel about NeOnc Technologies Holdings IncGlobal Markets & Momentum Based Trading Ideas - baoquankhu1.vn
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards - Pensacola News Journal
New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America - newswire.com
Pharma News: Can WiMi Hologram Cloud Inc navigate macro headwindsJuly 2025 Action & Accurate Buy Signal Alerts - baoquankhu1.vn
NeOnc Technologies raises $16 million in private placement By Investing.com - Investing.com Nigeria
NeOnc Technologies Announces Private Placement Equity Financing Deal - The Globe and Mail
NeOnc to Raise Up to $16 Million Through Private Placement - marketscreener.com
NeOnc Technologies raises $16 million in private placement - Investing.com
NeOnc Technologies Secures Strategic PIPE Investment led by - GlobeNewswire
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management - Sahm
FOMO Trade: Does NeOnc Technologies Holdings Inc have declining or rising EPSPortfolio Gains Summary & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
NeOnc Technologies Signs Securities Purchase Agreement With Institutional Investor - TradingView
Is NeOnc Technologies Holdings Inc. exposed to political riskTrade Risk Report & Accurate Intraday Trade Tips - mfd.ru
Price Action: Will NeOnc Technologies Holdings Inc stock benefit from M AStock Surge & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Sectors: Is NeOnc Technologies Holdings Inc exposed to political riskWeekly Investment Summary & Accurate Technical Buy Alerts - baoquankhu1.vn
Can NeOnc Technologies Holdings Inc deliver consistent EPS growthJuly 2025 Action & Fast Gaining Stock Reports - baoquankhu1.vn
The Iranian businessman testing a cancer drug in IsraelGlobes - Globes - Israel Business News
Neonc Technologies (NASDAQ:NTHI) Upgraded at Zacks Research - Defense World
Chipmakers Recap: How volatile is Faraday Future Intelligent Electric Inc stockMarket Trend Summary & Reliable Price Breakout Signals - baoquankhu1.vn
NeOnc’s Intranasal NEO100 Trial Marks a New Step in Pediatric Brain Tumor Investing - TipRanks
Aug Highlights: Can NeOnc Technologies Holdings Inc stock hit analyst price targetsTrade Ideas & Comprehensive Market Scan Reports - Bộ Nội Vụ
Bond Watch: Will NeOnc Technologies Holdings Inc stock deliver shareholder valueWeekly Profit Summary & Free Expert Approved Momentum Trade Ideas - Bộ Nội Vụ
Neonc Technologies (NASDAQ:NTHI) Trading Up 1.7% – Here’s What Happened - Defense World
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies, Citing CNS Therapeutic Pipeline and 2026 Catalyst - citybuzz -
Neonc Technologies Holdings Inc Stock (NTHI) Financials Data
There is no financial data for Neonc Technologies Holdings Inc (NTHI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Neonc Technologies Holdings Inc Stock (NTHI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | President |
Nov 24 '25 |
Buy |
6.51 |
6,000 |
39,060 |
2,992,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer |
Nov 20 '25 |
Buy |
6.69 |
1,100 |
7,359 |
134,260 |
| Heshmatpour Amir F | President |
May 23 '25 |
Buy |
7.39 |
2,000 |
14,785 |
1,762,000 |
| CHEN THOMAS C | CEO |
May 21 '25 |
Buy |
7.25 |
2,759 |
20,002 |
548,959 |
| CHEN THOMAS C | CEO |
May 22 '25 |
Buy |
7.38 |
2,709 |
20,000 |
551,668 |
| GARNETT KEITHLY | CFO |
May 22 '25 |
Buy |
7.29 |
675 |
4,921 |
240,900 |
| GARNETT KEITHLY | CFO |
May 19 '25 |
Buy |
7.23 |
135 |
976 |
240,225 |
| Delshad Jim | Director |
May 12 '25 |
Buy |
7.22 |
5,000 |
36,110 |
55,310 |
| Delshad Jim | Director |
Mar 26 '25 |
Buy |
16.05 |
50 |
802 |
50,260 |
| Delshad Jim | Director |
Apr 17 '25 |
Buy |
6.92 |
50 |
346 |
50,310 |
3.69%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):